Microbix Biosystems
$0.2095
3
-$0.01-4.34% Tuesday 16:27
Statistics
Day High
0.2095
Day Low
0.2095
52W High
0.227
52W Low
0.154
Volume
8,500
Avg. Volume
7,454
Mkt Cap
29.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Sep 999
$0.25
Jun 999
$0.25
Mar 999
$0.25
Dec 998
$0.25
Sep 998
$0.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
13AugExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-12.22%Profit Margin
Unprofitable26.56MRevenue
-3.25MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MBXBF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Qiagen NV
QGEN
Mkt Cap7.62B
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Thermo Fisher Scientific
TMO
Mkt Cap172.66B
Becton Dickinson
BDX
Mkt Cap39.67B
Danaher
DHR
Mkt Cap125.4B
Repligen
RGEN
Mkt Cap7.14B
Abbott Laboratories
ABT
Mkt Cap153.99B
About
Microbix Biosystems Inc. is a life sciences enterprise that invents and markets unique biological and technological innovations designed to improve human health and well-being. Operating across North America, Europe, and other international markets, the company primarily produces essential biological reagents for the diagnostics industry. This includes antigens for immunoassays and its proprietary Quality Assessment and Proficiency (QAP) products. These QAPs are crucial for supporting clinical laboratory proficiency testing, aiding in assay development and validation, and streamlining lab workflows. Furthermore, Microbix leverages its biological knowledge and infrastructure to create other specialized products, such as its DxTM (viral transport medium) for stabilizing patient samples for laboratory analysis, and Kinlytic Urokinase, a biologic drug for treating blood clots. Its QAP offerings are sold to laboratory accreditation organizations, diagnostic firms, and clinical laboratories via a network of regional distributors. Founded in 1988, Microbix Biosystems Inc. is headquartered in Mississauga, Canada.
Show more...
CEO
Mr. Cameron L. Groome
Employees
100
Country
Canada
ISIN
CA59501P1045
Listings
0 Comments
Share your thoughts
FAQ
What is Microbix Biosystems stock price today?▼
The current price of MBXBF is $0.21 USD — it has decreased by -4.34% in the past 24 hours. Watch Microbix Biosystems stock price performance more closely on the chart.
What is Microbix Biosystems stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Microbix Biosystems stocks are traded under the ticker MBXBF.
Is Microbix Biosystems stock price growing?▼
MBXBF stock has fallen by -4.34% compared to the previous week, the month change is a +15.11% rise, over the last year Microbix Biosystems has showed a -2.56% decrease.
What is Microbix Biosystems market cap?▼
Today Microbix Biosystems has the market capitalization of 29.08M
When is the next Microbix Biosystems earnings date?▼
Microbix Biosystems is going to release the next earnings report on August 13, 2026.
What were Microbix Biosystems earnings last quarter?▼
MBXBF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Microbix Biosystems revenue for the last year?▼
Microbix Biosystems revenue for the last year amounts to 26.56M USD.
What is Microbix Biosystems net income for the last year?▼
MBXBF net income for the last year is -3.25M USD.
How many employees does Microbix Biosystems have?▼
As of June 24, 2026, the company has 100 employees.
In which sector is Microbix Biosystems located?▼
Microbix Biosystems operates in the Health & Wellness sector.
When did Microbix Biosystems complete a stock split?▼
Microbix Biosystems has not had any recent stock splits.
Where is Microbix Biosystems headquartered?▼
Microbix Biosystems is headquartered in Mississauga, Canada.